| Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity‐based anorexia M Scherma, V Satta, R Collu, MF Boi, P Usai, W Fratta, P Fadda British journal of pharmacology 174 (16), 2682-2695, 2017 | 49 | 2017 |
| The ketamine-like compound methoxetamine substitutes for ketamine in the self-administration paradigm and enhances mesolimbic dopaminergic transmission A Mutti, S Aroni, P Fadda, L Padovani, L Mancini, R Collu, AL Muntoni, ... Psychopharmacology 233 (12), 2241-2251, 2016 | 26 | 2016 |
| Impaired brain endocannabinoid tone in the activity‐based model of anorexia nervosa R Collu, M Scherma, F Piscitelli, E Giunti, V Satta, MP Castelli, R Verde, ... International Journal of Eating Disorders 52 (11), 1251-1262, 2019 | 24 | 2019 |
| Emotional profile of female rats showing binge eating behavior V Satta, M Scherma, E Giunti, R Collu, L Fattore, W Fratta, P Fadda Physiology & behavior 163, 136-143, 2016 | 20 | 2016 |
| Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat V Serra, L Fattore, M Scherma, R Collu, MS Spano, W Fratta, P Fadda Psychopharmacology 232 (1), 91-100, 2015 | 19 | 2015 |
| Altered brain levels of arachidonic acid-derived inflammatory eicosanoids in a rodent model of anorexia nervosa R Collu, JM Post, M Scherma, E Giunti, W Fratta, B Lutz, P Fadda, ... Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2020 | 18 | 2020 |
| Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders M Manchia, U Isayeva, R Collu, D Primavera, L Deriu, E Caboni, ... Brain Sciences 12 (12), 1666, 2022 | 12 | 2022 |
| Animal models of eating disorders M Scherma, R Collu, V Satta, E Giunti, P Fadda Psychiatric Disorders, 297-314, 2019 | 10 | 2019 |
| Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study D Primavera, M Manchia, L Deriu, M Tusconi, R Collu, M Scherma, ... BMJ open 7 (5), e014938, 2017 | 8 | 2017 |
| Food restriction and hyperactivity induce changes in corticolimbic brain dopamine and serotonin levels in female rats E Giunti, R Collu, S Dedoni, MP Castelli, W Fratta, M Scherma, P Fadda Behavioural Brain Research 444, 114374, 2023 | 5 | 2023 |
| Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients U Isayeva, M Manchia, R Collu, D Primavera, L Deriu, E Caboni, N Iaselli, ... European Psychiatry 65 (1), e71, 2022 | 5 | 2022 |
| The longitudinal trajectory of serum brain-derived neurotrophic factor (BDNF) levels in psychotic patients: a prospective observational study M Manchia, D Primavera, L Deriu, M Tusconi, R Collu, M Scherma, ... European College of Neuropsychopharmacology (ECNP) 2017 27, S913, 2017 | 4 | 2017 |
| The impact of depot and long acting injectable antipsychotics on serum levels of brain-derived neurotrophic factor in schizophrenic and schizoaffective patients: results of a … M Manchia, P Diego, L Deriu, E Caboni, MN Iaselli, D Sundas, M Tusconi, ... | 3 | 2018 |
| Angiotensin-converting enzyme inhibitors and statins therapies-induced changes in omics profiles in humans and transgenic tau mice R Collu, E Giunti, S Daley, M Chen, W Xia Biomedicine & Pharmacotherapy 168, 115756, 2023 | 2 | 2023 |
| Reduction of Phosphorylated Tau in Alzheimer’s Disease Induced Pluripotent Stem Cell-Derived Neuro-Spheroids by Rho-Associated Coiled-Coil Kinase Inhibitor Fasudil E Giunti, R Collu, S Daley, H Querfurth, P Morin, R Killick, RD Melamed, ... Journal of Alzheimer's Disease, 1-15, 2023 | 2 | 2023 |
| Effect of the ROCK inhibitor fasudil on the brain proteomic profile in the tau transgenic mouse model of Alzheimer's disease R Collu, Z Yin, E Giunti, S Daley, M Chen, P Morin, R Killick, STCW 3, ... Frontiers in Aging Neuroscience, 2024 | 1 | 2024 |
| Brain Inflammatory Eicosanoids M Scherma, R Collu, S Dedoni, W Fratta, P Fadda Eating Disorders, 451, 2023 | 1 | 2023 |
| P. 049 The impact of depot and long acting injectable antipsychotics on BDNF serum levels in psychosis: a 24-month longitudinal prospective study M Manchia, D Primavera, L Deriu, E Caboni, N Iaselli, M Tusconi, R Collu, ... European Neuropsychopharmacology 29, S54-S55, 2019 | 1 | 2019 |
| Effect of the ROCK inhibitor fasudil on the brain proteomic profile in the tau transgenic mouse model of Alzheimer's disease R COLLU, Z Yin, E Giunti, S Daley, M Chen, P Morin, R Killick, STC Wong, ... Frontiers in Aging Neuroscience 16, 1323563, 0 | 1 | |
| Possible role of endocannabinoid system in the physiopathology of eating disorders W Fratta, M Scherma, R Collu, P Fadda | 1 | |
Paola FaddaDipartimento di Scienze Biomediche在 unica.it 的电子邮件经过验证
